COSCIENS Biopharma, Inc. (CSCI.TO)
7.50
+0.26
(+3.59%)
CAD |
TSX |
Aug 25, 10:26
COSCIENS Biopharma Price : 7.50 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 7.26 | 7.26 | 7.24 | 7.24 | 1902.00 |
| Aug 21, 2026 | 7.30 | 7.30 | 7.30 | 7.30 | 300.00 |
| Aug 20, 2026 | 7.95 | 7.95 | 7.95 | 7.95 | 501.00 |
| Aug 19, 2026 | 7.50 | 7.94 | 7.50 | 7.94 | 810.00 |
| Aug 18, 2026 | 7.51 | 7.75 | 7.00 | 7.34 | 2400.00 |
| Aug 17, 2026 | 7.88 | 7.88 | 7.88 | 7.88 | 7.000 |
| Aug 14, 2026 | 7.86 | 7.88 | 7.86 | 7.88 | 786.00 |
| Aug 13, 2026 | 7.86 | 7.86 | 7.86 | 7.86 | 0.000 |
| Aug 12, 2026 | 7.77 | 7.86 | 7.77 | 7.86 | 2001.00 |
| Aug 11, 2026 | 7.72 | 7.72 | 7.62 | 7.62 | 900.00 |
| Aug 10, 2026 | 7.06 | 7.25 | 7.06 | 7.25 | 602.00 |
| Aug 07, 2026 | 7.05 | 7.05 | 7.05 | 7.05 | 0.000 |
| Aug 06, 2026 | 7.25 | 7.25 | 7.05 | 7.05 | 300.00 |
| Aug 05, 2026 | 7.05 | 7.07 | 7.05 | 7.07 | 636.00 |
| Aug 04, 2026 | 7.00 | 8.10 | 7.00 | 7.10 | 1361.00 |
| Jul 31, 2026 | 7.10 | 7.10 | 7.08 | 7.10 | 652.00 |
| Jul 30, 2026 | 7.11 | 7.15 | 7.10 | 7.15 | 419.00 |
| Jul 29, 2026 | 7.56 | 7.90 | 7.00 | 7.90 | 3434.00 |
| Jul 28, 2026 | 7.90 | 7.90 | 7.90 | 7.90 | 261.00 |
| Jul 27, 2026 | 7.70 | 7.70 | 7.70 | 7.70 | 1.000 |
| Jul 24, 2026 | 7.85 | 7.85 | 7.70 | 7.70 | 414.00 |
| Jul 23, 2026 | 7.75 | 7.75 | 7.75 | 7.75 | 1141.00 |
| Jul 21, 2026 | 7.76 | 7.76 | 7.56 | 7.75 | 1000.00 |
| Jul 20, 2026 | 7.90 | 7.90 | 7.55 | 7.55 | 2791.00 |
| Jul 17, 2026 | 8.00 | 8.00 | 8.00 | 8.00 | 4.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Spectral Medical, Inc. | 1.35 |
| Resverlogix Corp. | 0.105 |
| Theratechnologies, Inc. | 4.47 |
| Restart Life Sciences Corp. | 0.07 |
| Defence Therapeutics Inc | 0.51 |
Price Related Metrics
| PS Ratio | 0.6903 |
| Price to Book Value | 0.3780 |
| Earnings Yield | -82.71% |
| Market Cap | 7.960M |